Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

染色傷の診療所が必要なのか?

S H Ibbotson, M G Dahl, P M Farr

    Lancet (London, England)
    |November 18, 1995
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease.

    The British journal of dermatology·2021
    Same author

    Photodiagnostic services in the UK and Republic of Ireland: a British Photodermatology Group Workshop Report.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2021
    Same author

    Minimal, superficial DNA damage in human skin from filtered far-ultraviolet C.

    The British journal of dermatology·2021
    Same author

    Is there an optimal irradiation dose for photodynamic therapy: 37 J cm<sup>-2</sup> or 75 J cm<sup>-2</sup> ?

    The British journal of dermatology·2019
    Same author

    Efficacy of localized hand and foot phototherapy: a review of patients treated in a teaching hospital setting.

    Clinical and experimental dermatology·2018
    Same author

    Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study.

    The British journal of dermatology·2018
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る